We are live on ! Find out more
EFM

E Fund Management Portfolio holdings

AUM $4.46B
This Fund
S&P 500
This Quarter Est. Return
+74.21%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$4.46B
AUM Growth
+$1.09B
Cap. Flow
-$3.1M
Cap. Flow %
-0.07%
Top 10 Hldgs %
49.45%
Holding
523
New
34
Increased
205
Reduced
238
Closed
35

Top Buys

Rank Stock Value
1
LRCX icon
Lam Research
LRCX
+$149M
2
AMD icon
Advanced Micro Devices
AMD
+$114M
3
ASML icon
ASML
ASML
+$83.3M
4
INTC icon
Intel
INTC
+$69.9M
5
KLAC icon
KLA
KLAC
+$61.9M

Top Sells

Rank Stock Value
1
LITE icon
Lumentum
LITE
+$172M
2
AXTI icon
AXT Inc
AXTI
+$110M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$97.9M
4
GLW icon
Corning
GLW
+$87.2M
5
TSEM icon
Tower Semiconductor
TSEM
+$79.8M

Sector Composition

Rank Sector Weight
1 Technology 66.9%
2 Consumer Discretionary 12.6%
3 Communication Services 5.91%
4 Miscellaneous 3.42%
5 Healthcare 3.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
APGE icon
226
Apogee Therapeutics
APGE
$625K 0.01%
4,706
-2,887
-38% -$260K
DIS icon
227
Walt Disney
DIS
$184B
$623K 0.01%
6,468
-31
-0.5% -$3.16K
ETN icon
228
Eaton
ETN
$158B
$614K 0.01%
1,442
-13
-0.9% -$5.24K
ELV icon
229
Elevance Health
ELV
$89.2B
$614K 0.01%
1,587
-332
-17% -$123K
MCK icon
230
McKesson
MCK
$107B
$607K 0.01%
803
+18
+2% +$14.3K
UNP icon
231
Union Pacific
UNP
$173B
$606K 0.01%
2,228
+40
+2% +$10.5K
WELL icon
232
Welltower
WELL
$173B
$603K 0.01%
2,658
+86
+3% +$18.2K
KYMR icon
233
Kymera Therapeutics
KYMR
$9.7B
$597K 0.01%
5,209
-21,022
-80% -$1.81M
MUFG icon
234
Mitsubishi UFJ Financial
MUFG
$272B
$593K 0.01%
+29,790
New +$561K
DE icon
235
Deere & Co
DE
$189B
$592K 0.01%
934
+11
+1% +$6.37K
TWST icon
236
Twist Bioscience
TWST
$8.35B
$591K 0.01%
5,744
-6,356
-53% -$414K
TT icon
237
Trane Technologies
TT
$98.5B
$580K 0.01%
1,180
+370
+46% +$173K
ORKA
238
Oruka Therapeutics
ORKA
$6.17B
$579K 0.01%
6,079
+989
+19% +$65.9K
PAAS icon
239
Pan American Silver
PAAS
$21.2B
$568K 0.01%
12,686
-2,735
-18% -$147K
VRSN icon
240
VeriSign
VRSN
$26.1B
$568K 0.01%
2,257
-22
-1% -$6.11K
SCHW
241
Charles Schwab
SCHW
$189B
$564K 0.01%
6,117
-55
-0.9% -$5.02K
PRAX icon
242
Praxis Precision Medicines
PRAX
$9.92B
$564K 0.01%
1,684
-272
-14% -$86.1K
HPQ icon
243
HP
HPQ
$28.7B
$553K 0.01%
25,199
-478
-2% -$10.6K
CI icon
244
Cigna
CI
$74.7B
$549K 0.01%
1,991
-153
-7% -$43.2K
VKTX icon
245
Viking Therapeutics
VKTX
$3.95B
$547K 0.01%
14,026
-1,830
-12% -$59.1K
RVMD icon
246
Revolution Medicines
RVMD
$44.9B
$544K 0.01%
2,907
-2,933
-50% -$428K
MSCI icon
247
MSCI
MSCI
$40.9B
$540K 0.01%
+964
New +$562K
MOMO
248
Hello Group
MOMO
$711M
$538K 0.01%
92,825
-14,416
-13% -$86K
T icon
249
AT&T
T
$179B
$534K 0.01%
25,791
-394
-2% -$9.78K
YALA
250
Yalla Group
YALA
$826M
$529K 0.01%
+96,323
New +$597K

Similar funds

E Fund Management's Q2 2026 Portfolio in Review

As of Q2 2026, E Fund Management held 523 positions worth $4.46B, up 32% from $3.37B the previous quarter. Its ten largest holdings account for 49% of the portfolio.

E Fund Management's Q2 2026 filing shows 34 new, 205 increased, 238 reduced and 35 closed positions. Its largest new stake was Astera Labs: 196,877 shares worth $95.1M. The largest sale was Lumentum, an estimated $172M.

By sector, the portfolio is most concentrated in Technology at 67% of assets, up from 52% a quarter earlier, followed by Consumer Discretionary and Communication Services.

  • E Fund Management's largest Q2 2026 buy was Astera Labs: 196,877 shares worth $95.1M.
  • E Fund Management added most to Lam Research in Q2 2026, an estimated $149M increase.
  • E Fund Management's biggest Q2 2026 reduction was Lumentum, cutting an estimated $172M.
  • E Fund Management fully exited SPDR Gold MiniShares Trust in Q2 2026, selling an estimated $13.4M.
  • E Fund Management's ten largest holdings make up 49% of its $4.46B portfolio in Q2 2026.
  • E Fund Management opened 34 new positions and closed 35 in Q2 2026.
  • E Fund Management's portfolio value rose 32% quarter-over-quarter to $4.46B.

Based on E Fund Management's 13F filing for Q2 2026, filed 11 Aug 2026.